Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Oncology Therapeutics, Inc

11.95
+0.97008.83%
Post-market: 12.300.3500+2.93%19:19 EDT
Volume:164.02K
Turnover:1.89M
Market Cap:946.40M
PE:-0.04
High:11.96
Open:11.01
Low:11.01
Close:10.98
52wk High:13.18
52wk Low:8.50
Shares:79.20M
Float Shares:44.60M
Volume Ratio:0.53
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-268.5581
EPS(LYR):-511.8002
ROE:--
ROA:--
PB:-4.16
PE(LYR):-0.02

Loading ...

Company Profile

Company Name:
BridgeBio Oncology Therapeutics, Inc
Exchange:
NASDAQ
Establishment Date:
2016
Employees:
- -
Office Location:
256 E. Grand Avenue,Suite 104,South San Francisco,California,United States
Website:
- -
Zip Code:
94080
Fax:
- -
Introduction:
- -

Directors

Name
Position
Eli Wallace
Chief Executive Officer and Director
Frank P. McCormick
Director and Chairman of the board
Bihua Chen
Director
Jake Bauer
Director
Michelle Doig
Director
Neil Kumar
Director
Praveen Tipirneni
Director
Raymond Kelleher
Director

Shareholders

Name
Position
Eli Wallace
Chief Executive Officer and Director
Uneek Mehra
Chief Financial Officer
Pedro J. Beltran
Chief Scientific Officer
Yong Ben
Chief Medical and Development Officer